Secondary Logo

Journal Logo

Editorial introductions

Klastersky, Jean A.; Pirker, Robert; Curigliano, Giuseppe

doi: 10.1097/CCO.0000000000000498

Current Opinion in Oncology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of psychiatry is divided into 15 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Editor and Section Editors for this issue.

Back to Top | Article Outline


Jean A. Klastersky

Jean A. Klastersky was born March 3, 1940, in Prague.

Professor Klastersky was Head of the Department of Medicine at the Institut Jules Bordet in Brussels, Belgium, and Professor of Medicine, Medical Oncology and Physical Diagnosis at the Université Libre de Bruxelles, Belgium, from 1977. He retired from these positions in 2005. Currently, he is the coordinator of the “Programme des Soins Oncologiques” for the Public Hospitals in Brussels and consultant in medical oncology at the Institut Jules Bordet, Belgium.

Professor Klastersky was an intern and resident at the University Hospitals of the Université Libre de Bruxelles between 1962 and 1965, where he gained his MD (Docteur en Médecine, Chirurgie et Accouchements). From 1967 to 1968, he was Chief-Resident at Boston City Hospital, USA, and then a Research Fellow and Assistant in Medicine at Thorndike Memorial Laboratory Harvard Medical School, USA. He became Chief of the Section of Infectious Diseases at the Institut Jules Bordet in 1970, before taking up the position of Head of the Department of Medicine in 1977.

Professor Klastersky was a founder member of the European Lung Cancer Working Party and was President from 1978 until 2003. He was President (and founder member) of the International EORTC Antimicrobial Therapy Project Group between 1979 and 1987 and the Group's Secretary General from 1987 to 2000. He was President (and founder member) of the Multinational Association for Supportive Care in Cancer (MASCC) from 1990 to 2000.

He has been Visiting Professor of Medical Oncology at the Charles University in Prague, Czech Republic, since 1994.

Professor Klastersky is a member of the American Society of Clinical Oncology, the American Association of Cancer Research, the European Society of Medical Oncology, the American Society of Microbiology, the Infectious Diseases Society of America, the International Association for the Study of Lung Cancer, the “Royale Académie de Médecine” of Belgium and various other international and national medical and/or oncological societies.

Professor Klastersky is the author of over 400 original articles, nearly 400 review articles and 17 scientific books.

He is the Editor of Current Opinion in Oncology.

Back to Top | Article Outline


Robert Pirker

Robert Pirker is currently Professor of Medicine and Program Director for Lung Cancer at the Department of Medicine I, Medical University of Vienna, Austria. He obtained a master's degree in Biochemistry in 1978 and his medical degree in 1979 from the University of Vienna. Robert Pirker trained in internal medicine, hemato-oncology and nuclear medicine at the University of Vienna. He also worked as NIH Visiting Fellow at the Laboratory of Molecular Biology (Chief: Dr Ira Pastan), National Cancer Institute, Bethesda, MD, USA (1983–86).

His research interests are chemotherapy and targeted therapy of lung cancer, drug resistance mechanisms of cancer, and management of chemotherapy-induced anaemia. He has published more than 200 articles, reviews or book chapters. He is a current member of the IASLC Board of Directors. He was Congress President of the 8th and 14th Central European Lung Cancer Congresses, Chair of the Scientific Committee of the European Multidisciplinary Conference on Thoracic Oncology in 2009, and Conference President of the IASLC 17th World Conference on Lung Cancer in 2016 in Vienna.

Back to Top | Article Outline

Giuseppe Curigliano

Giuseppe Curigliano, MD, PhD, is an ESMO Member. He is Associate Professor of Medical Oncology at University of Milan, Italy, and the Head of the Division of Early Drug Development at European Institute of Oncology, Italy. He is a clinician and researcher specializing in early drug development for patients with solid tumors with a special commitment to breast cancer. He has been an ESMO Breast Faculty Member since 2001 and served on the Program Scientific Committee of the St Gallen Conference since 2011, and as Scientific Chair in St Gallen in 2017. He has been appointed as Editor of Annals of Oncology for the period 2014–2018 and 2018–2020, and serves as co-Editor-in-Chief of The Breast, co-Editor-in-Chief of Cancer Treatment Reviews, Associate Editor of the European Journal of Cancer, as well as Editor of the Journal of Clinical Oncology and Current Opinion in Oncology. He also serves on the European School of Oncology (ESO) faculty committee.

Dr Curigliano serves ESMO as a member of the ESMO Press & Media Affairs Committee, and has been in the ESMO Women for Oncology Committee, the ESMO Membership and ESMO Global Policy Committees since 2016.

He was elected as member of the ESMO Nominating Committee in 2017.

He served as the scientific chair of the IMPAKT meeting that was held in Brussels in 2014 and as the Breast Cancer (metastatic) Track Chair of the ESMO 2014 meeting in Madrid. He will co-chair the first ESMO Breast Cancer Congress in 2019.

Dr Curigliano was awarded with the first ESO Umberto Veronesi Award in Vienna in 2017 and with the Fellowship of the European Academy of Cancer Sciences in Paris in 2017.

He has contributed to over 300 peer-reviewed publications.

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.